BEMPEDOIC ACID / EZETIMIBE (Nustendi®)

Clinical Indication

Primary hypercholesterolaemia or mixed dyslipidaemia in adults

Comments

In line with NICE TA694

Implementation date 28th July 2021

Date of classification

October 2020

Review date

June 2021

Red

Drugs which should be prescribed only by hospital specialists (clinical review by specialist as appropriate and annually as a minimum).